The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

It is a fictional representation created for illustrative purposes only. The U.S. FDA approved Johnson & Johnson's Varipulse, ...

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

Blackrock Clinic performed the first procedure in Europe using VARIPULSE™ Pulsed Field Ablation Platform Blackrock Health performed the first procedure using the Varipulse™ Pulsed Field Ablation (PFA) ...

The Varipulse catheter comprises one key piece of the Varipulse platform. [image courtesy of Biosense Webster/Johnson & Johnson MedTech] Johnson & Johnson MedTech (NYSE: JNJ) + today announced the ...